November 2011

ANSWERS of Previous PharmaQUIZ-15:

1.C    2.B    3.D    4.A    5.D

6.A    7.C    8.B    9.C    10.D

Bristol-Myers Squibb Biocon R&D Center (BBRC) is a collaboration between Bristol-Myers Squibb and Syngene International, a subsidiary of the Indian biotechnology major, Biocon. This initiative is intended to help advance Bristol-Myers Squibb's work in discovery and early drug development. The center is expanding its capabilities to clinical biomarkers, toxicology and first-in-human studies.

ANSWERS of Previous PharmaQUIZ-14:

1.C    2.A    3.B    4.B    5.C

6.A    7.B    8.A    9.D    10.C

The University Institute of Pharmaceutical Sciences of the Panjab University is a premier institution of Pharmaceutical Education and Research in the country. The institute has covered a long and glorious journey of 76 years starting from Lahore in 1944 and finally settling to the present campus in Chandigarh at the foothills of Himachal.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.

Virchow Biotech Private Limited (VBPL), an innovative biotechnology company headquartered at Hyderabad, India. VBPL also has offices located in the United States of America ( at Nashville, Tennessee)

About Authors: NIDHI KARIA¹, RAKHI CHANDAK¹, ARATI  RATHI²
1. P.WADHWANI COLLEGE OF PHARMACY,YAVATMAL
2. ASST PROFFESER AT SUMANDEEP DEPARMENT OF PHARMACY, VADODARA

INTRODUCTION:
The advent of the new drug delivery systems (oral, nasal, pulmonary, transdermal, needle-free, etc.) and the development of new biochemical compounds have resulted in a need not only for enhanced protection against such factors as moisture, light, oxygen, or mechanical forces, but also for packaging forms to play a more integral role in drug delivery. A large number of lyophilized or freeze-dried drugs, for example, are currently available, and the list is growing. Biotech drugs by their very nature are much less stable than conventional compounds and demand a different mode of delivery. In this article, we will describe in more detail several examples of delivery systems to show how packaging, with an emphasis on blister and flexible materials, is being put to the test today.